Verona Pharma Share Price (VRP)
| Bid price | 45.00 | Open price | 0.00 |
|---|---|---|---|
| Ask price | 65.00 | Prev close | 55.00 |
| High price | 0.00 | Spread | 0.00% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Verona Pharma share prices, Verona Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Verona Pharma Level 2 Data, indepth research tools and investor commentary for Verona Pharma (VRP) and other London Stock Exchange equities.
Verona Pharma Share Price Chart
Register now for FREE Verona Pharma share price charts
Verona Pharma Share Price Information
| Name | Verona Pharma | Epic | VRP |
|---|---|---|---|
| Sector | n/a | ISIN | GB00BYW2KH80 |
| Activites | n/a | Index | n/a |
Verona Pharma Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 04/08/2020 | SELL | David Zaccardelli | CEO | 43,392 |
| 04/08/2020 | TIN | David Zaccardelli | CEO | 178,200 |
| 17/07/2020 | PLAC | David Ebsworth | CH | 222,216 |
| 17/07/2020 | BUY | Martin Edwards | NED | 53,328 |
| 17/07/2020 | BUY | David Zaccardelli | CEO | 444,440 |
Verona Pharma Company News
Verona Pharma secures $30m debt facility from Silicon Valley Bank
Respiratory diseases focused Verona Pharma said it had entered into a debt financing facility for up to $30 million with Silicon Valley Bank. The capital provided further financial flexibility to support pre-commercialization activities for ensifentrine, a product candidate currently in Phase 3...
Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank
Non-dilutive capital to provide further financial flexibility LONDON and RALEIGH, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases,...
Verona Pharma Announces November 2020 Virtual Investor Conference Participation
LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company...
More Verona Pharma Company News >>
Register now for FREE Verona Pharma company news
Verona Pharma Share Price Discussions
Anyone in Verona Pharma plc ? Target = 14p+ Pos+ treatment just round the corner ! (VRP)
Bought in this morning...@5.45p showed as a sell. Prospects are good. There are targets of 14p around 20 May 2009 Verona Pharma plc ("Verona Pharma" or the "Company") First two...
Register now for FREE Verona Pharma share price discussions